Sanofi

Genzyme, Sanofi at Odds Over Threshold Price

Genzyme, Sanofi Silence May Indicate Talks

European Staff Fight Back As Drugmakers Hack Costs

Genzyme Has Little Leverage To Play Hardball

Novartis/Alcon Deal Cleared by EU Regulators

Sanofi Faces Long Summer Haggling Over Genzyme Bid

Sanofi's Best Bet Still May Be Smaller Deals

Sanofi Investors Oppose Big Hike In Genzyme Bid

Sanofi Shareholders Want Genzyme For About $19 Billion

Sanofi Sends Offer Letter to Genzyme

White Knight Could Be Elusive For Genzyme

Sanofi Q2 Beats Forecast as Genzyme Deal Looms

Sanofi Q2 Beats Market; Mum On Genzyme Bid Talk

Sanofi to Press Ahead on Genzyme Bid

Genzyme Weighs Sanofi Approach, Not Keen to Sell

Genzyme Seen More Attractive To Sanofi Than Glaxo

Sanofi Makes Informal Approach To Genzyme

Pharming Signs Manufacturing Deal with Sanofi-Aventis

Sanofi Declines Comment on U.S. Deal

Sanofi Buys TargeGen to Boost Cancer Treatments

Big Pharma Stocks Could Rally in the Next Year

EU Drugs Agency Under Fire Again For Data Secrecy

Roche Maintains Focus as Industry Faces Cutbacks

Sanofi to Invest in Japanese Generic Drug Maker

Bayer Sees Sharp Growth in Chinese Medical Market

Sanofi to Invest $200 Million in French Biotech Plants

Bayer Still Out To Buy, Not Sell, Vet Businesses

AstraZeneca Mulls Production in Russia

China Drug List Seen Boosting Western Firms' Sales

Pandemic Has Not Yet Peaked, WHO Experts Advise

Sanofi Remodels R&D

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Predictive Simulation in Pharma Production

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.